Herpes simplex infection in urothelial carcinoma

Virchows Archiv

Volumn 445, Issue 1, 2004, Pages 68-73

  Kaku, Naomi ^a   Kashima, Kenji ^a   Daa, Tsutomu ^a   Nakayama, Iwao ^a   Yokoyama, Shigeo ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Herpes simplex virus; Immunohistochemical staining; Non neoplastic urothelium; Polymerase chain reaction; Urothelial carcinoma

Indexed keywords

ARTICLE; AUTOPSY; CANCER INVASION; CONTROLLED STUDY; FEMALE; HERPES SIMPLEX; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; UROGENITAL TRACT CANCER; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; DNA, NEOPLASM; DNA, VIRAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HERPES SIMPLEX; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SIMPLEXVIRUS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 3843082904     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Cleator GM, Klapper PE (1994) Herpes simplex. In: Zuckerman AJ, Banatvala JE, Pattison JR (eds) Principles and practice of clinical virology, 3rd edn. Wiley, Chichester, pp 5-36
2. Di Paolo JA, Woodworth CD, Popescu NC, Koval DL, Lopez JV, Doniger J (1990) HSV-2-induced tumorigenicity in HPV-16 immortalized human genital keratinocytes. Virology 177:777-779
3. Gazzaniga P, Vercillo R, Gradilone A, Silvestri I, Gandini O, Napolitano M, Giuliani L, Fioravanti A, Gallucci M, Aglianò AM (1998) Prevalence of papillomavirus, Epstein-Barr virus, cytomegalovirus, and herpes simplex virus type 2 in urinary bladder cancer. J Med Virol 55:262-267
4. Haid M, Sharon N (1984) Immunofluorescent evidence of prior herpes simplex virus type-2 infection in prostate carcinoma. Urology 113:623-625
5. Hamsíková E, Ludvíková V, Tachezy R, Kovarík J, Brousková L, Vonka V (2000) Longitudinal follow-up of antibody response to selected antigens of human papillomaviruses and herpesviruses in patients with invasive cervical carcinoma. Int J Cancer 86:351-355
6. Hildesheim A, Mann V, Brinton LA, Szklo M, Reeves WC, Rawls WE (1991) Herpes simplex virus type 2: a possible interaction with human papilloma virus types 16/18 in the development of invasive cervical cancer. Int J Cancer 49:335-340
7. Kitaeva MN, Grogan L, Williams JP, Dimond E, Nakahara K, Hausner P, Denobile JW, Soballe PW, Kirsch IR (1997) Mutations in β-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. Cancer Res 57:4478-4481
8. Kjaer SK, De Villiers E-M, Çaglayan H, Svare E, Haugaard BJ, Engholm G, Christensen RB, Moller KA, Poll P, Jensen H, Vestergaard BF, Lynge E, Jensen OM (1993) Human papillomavirus, herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark) - a second look. Br J Cancer 67:830-837
9. McClanahan C, Grimes MM, Callaghan E, Stewart J (1994) Hemorrhagic cystitis associated with herpes simplex virus. J Urol 151:152-153
10. Messing EM, Catalona W (1996) In: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ (eds) Urothelial tumors of the urinary tract. Campbell's Urology, 7th edn. Saunders, Philadelphia, p 2335
11. Mostofi FK (1999) Histological typing of urinary bladder tumors. In: Davis CJ, Sesterhenn IA (eds) World Health Organization International Histological Classification of Tumors, 2nd edn. Springer-Verlag, Berlin Heidelberg New York, p 9
12. Schmauz R, Okong P, De Villiers E-M, Dennin R, Brade L, Lwanga SK, Owor R (1989) Multiple infections in cases of cervical cancer from a high-incidence area in tropical Africa. Int J Cancer 43:805-809
13. Superti F, Longhi C, Di Biase AM, Tinari A, Marchetti M, Pisani S, Gallinelli C, Chiarini F, Seganti L (2001) Herpes simplex virus type 2 modulates the susceptibility of human bladder cells to uropathogenic bacteria. Med Microbiol Immunol 189:201-208
14. Tarro G, Flaminio G, Maturo S, Esposito C, Cocchira R (1982) Further studies on an immunoenzymatic assay for herpes simplex virus tumor-associated antigen. Clin Immunol Immunopathol 25:126-132
15. Whitley RJ, Roizman B (2001) Herpes simplex virus infections. Lancet 357:1513-1518